Entering text into the input field will update the search result below

In-Depth Analysis Of The COVID-19 Impact On Global Animal Genetics Market 2021

May 27, 2021 10:36 AM ETNeogen Corporation (NEOG)
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • Increasing Consumption of Animal-Derived Protein.
  • Growing Global Population and Rapid Urbanization.

The Research Report on “Animal Genetics Market by Products & Services (Live Animals (Poultry, Porcine, Bovine, Canine) Genetic Material (Semen (Bovine, Porcine), Embryo (Bovine, Equine)) Genetic Testing (DNA Testing, DNA Typing, Genetic Disease Testing)) – Forecast” published by MarketsandMarkets™, is projected to reach USD 5.8 billion, at a CAGR of 6.5 % during the forecast period.

The Factors such as growing population and rapid urbanization across the globe, increased affordability and preference for animal protein, increased adoption of genetic services and advanced genetic practices such as artificial insemination and embryo transfer for larger-scale production and quality breeds, and growing focus on identifying superior breeds are likely to boost the growth of the market.

Request Research Sample Pages: Animal Genetics Market

Live porcine is expected to grow at the fastest CAGR during the forecast period.

Based on live animal type, the porcine segment is expected to grow at the fastest CAGR during the forecast period. This can be attributed to the large consumer base of pork and pork products, and the increasing penetration of advanced veterinary genetic research into this segment.

Geographical View in-detailed:

The Animal Genetic Market has been studies for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate the animal genetics market during the forecast period. This is attributed to the presence of a large number of leading players of the market in this regions, along with the high adoption of the latest technologies in animal genetics. Besides, the establised livestock sector, and the growing demand for animal protien is expecetd to drive the North American market.

Global Key Leaders:

Some of the prominent players in the animal genetics market are Neogen Corporation (US), Genus (UK), URUS (US), EW Group (Germany), Groupe Grimaud (France), Zoetis (US), CRV Holding (Netherlands), Topigs Norsvin (Netherlands), Envigo (US), and Hendrix Genetics (Netherlands).

Download PDF Brochure: Animal Genetics Market

Genus held the leading position in the market for porcine segment in 2017, and is also one of the leading players in the bovine animal genetics market. The company has a strong product portfolio of live porcine and bovine as well as animal semen. The company has a strong geographic footprint and a base of more than 50,000 customers including world leading milk and meat producers. The company’s international sales accounted for approximately 84% of its total sales in 2017. The company has a continuous focus on both organic and inorganic growth strategies like product launches, acquisitions, and partnerships to create new opportunities for market growth.

EW Group (Germany) holdings a leading position in the poultry genetics market in 2017. Aviagen (a subsidiary of EW Group) is a leader in the market for broilers and turkey genetics, whereas Lohmann Tierzucht and other subsidiaries of EW Group are leading the market in the white layers segment. With its four major subsidiaries, the company offers poultry products across the globe. Aviagen focuses on both organic and inorganic growth strategies. The company is also focusing on increasing its geographical presence through investments made in opening new hatchery in different countries.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.